Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB vs SECNIDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARILUMAB vs SECNIDAZOLE: Safety Overview

Metric SARILUMAB SECNIDAZOLE
Total FAERS Reports 21,493 245
Deaths Reported 1,983 1
Death Rate 9.2% 0.4%
Hospitalizations 3,538 10
Average Patient Age 57.5 yrs 40.4 yrs
% Female Patients 84.4% 95.6%
FDA Approval Date N/A Sep 15, 2017
Manufacturer Sanofi-Aventis U.S. LLC Evofem Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription